Medizinische Universität Graz - Research portal
Selected Publication:
SHR Neuro Cancer Cardio Lipid Metab Microb
Van Biesen, W; Jha, V; Abu-Alfa, AK; Andreoli, SP; Ashuntantang, G; Bernieh, B; Brown, E; Chen, Y; Coppo, R; Couchoud, C; Cullis, B; Douthat, W; Eke, FU; Hemmelgarn, B; Hou, FF; Levin, NW; Luyckx, VA; Morton, RL; Moosa, MR; Murtagh, FEM; Richards, M; Rondeau, E; Schneditz, D; Shah, KD; Tesar, V; Yeates, K; Garcia Garcia, G.
Considerations on equity in management of end-stage kidney disease in low- and middle-income countries.
Kidney Int Suppl (2011). 2020; 10(1):e63-e71-e63-e71
Doi: 10.1016/j.kisu.2019.11.004
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
- Co-authors Med Uni Graz
- Schneditz Daniel
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- Achievement of equity in health requires development of a health system in which everyone has a fair opportunity to attain their full health potential. The current, large country-level variation in the reported incidence and prevalence of treated end-stage kidney disease indicates the existence of system-level inequities. Equitable implementation of kidney replacement therapy (KRT) programs must address issues of availability, affordability, and acceptability. The major structural factors that impact equity in KRT in different countries are the organization of health systems, overall health care spending, funding and delivery models, and nature of KRT prioritization (transplantation, hemodialysis or peritoneal dialysis, and conservative care). Implementation of KRT programs has the potential to exacerbate inequity unless equity is deliberately addressed. In this review, we summarize discussions on equitable provision of KRT in low- and middle-income countries and suggest areas for future research. © 2020 International Society of Nephrology. Published by Elsevier Inc. All rights reserved.